Agreed, I am however surprised that the dodgy gums treatment has not progressed more quickly as that one is not really for internal consumption as it is a mouthwash or chewing gum so the approval process is much quicker.
Given IHL's position in the dental market you would have thought that periodontitis treatments would be easy to sell.
Anyway I expect news re Cannvalate before Christmas as they have some options to exercise this month plus I would like to know how the oils sales are going - assuming no supply issues there.
Plenty to come which is starting to be reflected in depth with 16mn buys versus 3mn sells.
There are also very few options for sale even at a premium, all we need now are for some of those bids in depth to get bored and step up to the offer and off it will go.
EB
IHL Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held
